TY - JOUR
T1 - CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024
AU - The Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention, Therapeutics (CVIT)
AU - Ozaki, Yukio
AU - Tobe, Akihiro
AU - Onuma, Yoshinobu
AU - Kobayashi, Yoshio
AU - Amano, Tetsuya
AU - Muramatsu, Takashi
AU - Ishii, Hideki
AU - Yamaji, Kyohei
AU - Kohsaka, Shun
AU - Ismail, Tevfik F.
AU - Uemura, Shiro
AU - Hikichi, Yutaka
AU - Tsujita, Kenichi
AU - Ako, Junya
AU - Morino, Yoshihiro
AU - Maekawa, Yuichiro
AU - Shinke, Toshiro
AU - Shite, Junya
AU - Igarashi, Yasumi
AU - Nakagawa, Yoshihisa
AU - Shiode, Nobuo
AU - Okamura, Atsunori
AU - Ogawa, Takayuki
AU - Shibata, Yoshisato
AU - Tsuji, Takafumi
AU - Hayashida, Kentaro
AU - Yajima, Junji
AU - Sugano, Teruyasu
AU - Okura, Hiroyuki
AU - Okayama, Hideki
AU - Kawaguchi, Katsuhiro
AU - Zen, Kan
AU - Takahashi, Saeko
AU - Tamura, Toshihiro
AU - Nakazato, Kazuhiko
AU - Yamaguchi, Junichi
AU - Iida, Osamu
AU - Ozaki, Reina
AU - Yoshimachi, Fuminobu
AU - Ishihara, Masaharu
AU - Murohara, Toyoaki
AU - Ueno, Takafumi
AU - Yokoi, Hiroyoshi
AU - Nakamura, Masato
AU - Ikari, Yuji
AU - Serruys, Patrick W.
AU - Kozuma, Ken
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10
Y1 - 2024/10
N2 - Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023. Major new updates in the 2023 ESC guideline include: (1) intravascular imaging should be considered to guide PCI (Class IIa); (2) timing of complete revascularization; (3) antiplatelet therapy in patient with high-bleeding risk. Reflecting rapid advances in the field, the Task Force on Primary PCI of the CVIT group has now proposed an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2024 version.
AB - Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023. Major new updates in the 2023 ESC guideline include: (1) intravascular imaging should be considered to guide PCI (Class IIa); (2) timing of complete revascularization; (3) antiplatelet therapy in patient with high-bleeding risk. Reflecting rapid advances in the field, the Task Force on Primary PCI of the CVIT group has now proposed an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2024 version.
KW - Acute coronary syndrome (ACS)
KW - Non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
KW - Non-ST-segment elevation acute myocardial infarction (NSTEMI)
KW - Percutaneous coronary intervention (PCI)
KW - ST-segment elevation acute my cardial infarction (STEMI)
UR - https://www.scopus.com/pages/publications/85204722595
UR - https://www.scopus.com/pages/publications/85204722595#tab=citedBy
U2 - 10.1007/s12928-024-01036-y
DO - 10.1007/s12928-024-01036-y
M3 - Article
C2 - 39302533
AN - SCOPUS:85204722595
SN - 1868-4300
VL - 39
SP - 335
EP - 375
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
IS - 4
ER -